Nuclear magnetic resonance-determined lipoprotein subclasses and carotid intima-media thickness in type 1 diabetes

被引:19
作者
Basu, Arpita [1 ]
Jenkins, Alicia J. [2 ,3 ]
Zhang, Ying [4 ]
Stoner, Julie A. [4 ]
Klein, Richard L. [5 ,6 ]
Lopes-Virella, Maria F. [5 ,6 ]
Garvey, W. Timothy [7 ]
Lyons, Timothy J. [2 ,8 ]
机构
[1] Oklahoma State Univ, Dept Nutr Sci, Stillwater, OK 74078 USA
[2] Univ Oklahoma, Hlth Sci Ctr, Sect Endocrinol & Diabet, Oklahoma City, OK USA
[3] Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW 2006, Australia
[4] Univ Oklahoma, Hlth Sci Ctr, Dept Biostat & Epidemiol, Oklahoma City, OK USA
[5] Med Univ S Carolina, Div Endocrinol, Charleston, SC 29425 USA
[6] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC USA
[7] Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA
[8] Queens Univ Belfast, Ctr Med Expt, Belfast BT12 6BA, Antrim, North Ireland
基金
美国国家卫生研究院;
关键词
Type; 1; diabetes; LDL particles; Non-HDL cholesterol; Nuclear magnetic resonance-determined; lipoprotein subclass profiles; LOW-DENSITY-LIPOPROTEIN; CORONARY-ARTERY-DISEASE; PARTICLE-SIZE; COMPLICATIONS TRIAL/EPIDEMIOLOGY; SUBCLINICAL ATHEROSCLEROSIS; PITTSBURGH EPIDEMIOLOGY; DCCT/EDIC COHORT; RISK-FACTOR; CHOLESTEROL; PROGRESSION;
D O I
10.1016/j.atherosclerosis.2015.10.106
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Dyslipidemia has been linked to vascular complications of Type 1 diabetes (T1DM). We investigated the prospective associations of nuclear magnetic resonance-determined lipoprotein subclass profiles (NMR-LSP) and conventional lipid profiles with carotid intima-media thickness (IMT) in T1DM. Methods: NMR-LSP and conventional lipids were measured in a subset of Diabetes Control and Complications Trial (DCCT) participants (n = 455) at study entry ('baseline', 1983-89), and were related to carotid IMT determined by ultrasonography during the observational follow-up of the DCCT, the Epidemiology of Diabetes Interventions and Complications (EDIC) study, at EDIC Year 12 (2004-2006). Associations were defined using multiple linear regression stratified by gender, and following adjustment for HbA1c, diabetes duration, body mass index, albuminuria, DCCT randomization group, smoking status, statin use, and ultrasound devices. Results: In men, significant positive associations were observed between some baseline NMR-subclasses of LDL (total IDL/LDL and large LDL) and common and/or internal carotid IMT, and between conventional total- and LDL-cholesterol and non-HDL-cholesterol and common carotid IMT, at EDIC Year 12; these persisted in adjusted analyses (p < 0.05). Large LDL particles and conventional triglycerides were positively associated with common carotid IMT changes over 12 years (p < 0.05). Inverse associations of mean HDL diameter and large HDL concentrations, and positive associations of small LDL with common and/or internal carotid IMT (all p < 0.05) were found, but did not persist in adjusted analyses. No significant associations were observed in women. Conclusion: NMR-LSP-derived LDL particles, in addition to conventional lipid profiles, may help in identifying men with T1DM at highest risk for vascular disease. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:93 / 100
页数:8
相关论文
共 48 条
[1]  
Al-Shahrouri HZ, 2010, CLIN NEPHROL, V73, P180
[2]  
[Anonymous], 1997, CIRCULATION
[3]  
[Anonymous], ANN N Y ACAD SCI
[4]  
[Anonymous], DIABETES
[5]  
[Anonymous], DATA BRIEF
[6]  
[Anonymous], ANN N Y ACAD SCI
[7]  
[Anonymous], CLIN CHEM
[8]   National Lipid Association Annual Summary of Clinical Lipidology 2015 [J].
Bays, Harold E. ;
Jones, Peter H. ;
Brown, W. Virgil ;
Jacobson, Terry A. .
JOURNAL OF CLINICAL LIPIDOLOGY, 2014, 8 (06) :S1-S36
[9]   Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes [J].
Berneis, K ;
Jeanneret, C ;
Muser, E ;
Felix, B ;
Miserez, AR .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2005, 54 (02) :227-234
[10]   Intimal-medial thickness of the carotid artery in nondiabetic and NIDDM patients - Relationship with insulin resistance [J].
Bonora, E ;
Tessari, R ;
Micciolo, R ;
Zenere, M ;
Targher, G ;
Padovani, R ;
Falezza, G ;
Muggeo, M .
DIABETES CARE, 1997, 20 (04) :627-631